American Healthcare REIT filings document the reporting framework for a NYSE-listed healthcare REIT with common stock and an operating partnership. Recent 8-K reports furnish earnings releases, financial-position updates, supplemental operating data, distribution authorizations and Regulation FD materials tied to the company's real estate portfolio and segment performance.
Other filings cover material financing arrangements, including credit-facility amendments and an at-the-market equity offering program, as well as proxy disclosures on board governance, executive compensation and stockholder voting matters. Leadership-transition reports and related compensatory arrangements are documented through Form 8-K and amended Form 8-K disclosures.
American Healthcare REIT, Inc. entered into a new at-the-market equity offering program allowing sales of up to $1.75 billion of common stock through multiple banks acting as agents or forward sellers. This replaces a prior program that had $230,139,575 of capacity remaining when it was terminated.
The company may also use forward sale agreements, under which forward purchasers borrow and sell shares, with the company later choosing physical, cash or net share settlement. Net cash proceeds the company ultimately receives are expected to be contributed to its operating partnership and used for general corporate purposes, including potential debt repayment, working capital, capital expenditures and future investments.
American Healthcare REIT, Inc. entered into an ATM Equity Offering Sales Agreement to offer shares of its common stock having an aggregate gross sales price of up to $1,750,000,000, replacing a prior $1,000,000,000 ATM. Sales may occur from time to time through listed agents and via negotiated or at-the-market transactions.
The company expects to contribute net proceeds to its Operating Partnership in exchange for OP Units and anticipates that forward sale agreements may be used; physical settlement of forwards is expected on or prior to maturity, though cash or net share settlement is permitted under the forward sale terms.
American Healthcare REIT, Inc. is a self-managed healthcare REIT that acquires, owns and operates clinical real estate focused on senior housing, integrated senior health campuses, skilled nursing facilities and outpatient medical buildings in the U.S., U.K. and Isle of Man. It conducts most operations through American Healthcare REIT Holdings, LP, owning 99.0% of the operating partnership as of December 31, 2025. The company completed a major underwritten public offering in February 2024, issuing 64,400,000 shares of Common Stock for $772,800,000 in gross proceeds, and listed on the NYSE under the symbol AHR. As of February 18, 2026, it had 188,028,542 shares of Common Stock outstanding. The portfolio is organized into four segments—integrated senior health campuses, outpatient medical, senior housing operating properties and triple-net leased properties—with meaningful geographic concentration in Indiana and Ohio. The REIT has elected to be taxed as a REIT since 2016, targets current income and long-term appreciation, uses RIDEA structures for many operating assets, and pursues growth through disciplined acquisitions, selective development and joint ventures while managing leverage and interest-rate risk. It highlights extensive healthcare regulatory exposure, reimbursement risk, tenant credit risk, cybersecurity, and inflation pressures as key risk factors, and emphasizes corporate responsibility and human capital programs for its approximately 121 employees.
American Healthcare REIT, Inc. reported strong fourth quarter and full-year 2025 results and issued 2026 guidance. Same-store NOI grew 11.8% in Q4 2025 and 14.2% for the year, led by 18.4% ISHC and 25.2% SHOP segment growth.
Full-year net income attributable to controlling interest was $69.8 million, or $0.42 per diluted share, versus a loss in 2024. NAREIT FFO per diluted share rose to $1.76 from $1.26, and Normalized FFO per diluted share increased to $1.72 from $1.41.
The company completed over $950 million of 2025 acquisitions, expects approximately $178 million of development spend (with $66.9 million funded), and ended 2025 with $1.54 billion of consolidated debt, Net-Debt-to-Annualized Adjusted EBITDA of 3.4x, and about $1.14 billion of liquidity.
For 2026, guidance targets diluted net income per share of $0.75–$0.81, NAREIT FFO per share of $1.93–$1.99, Normalized FFO per share of $1.99–$2.05, and total portfolio same-store NOI growth of 7–11%, with SHOP same-store NOI growth of 15–19%.
Royal Bank of Canada has filed a beneficial ownership report showing a significant stake in American Healthcare REIT Inc. common stock. RBC reports beneficial ownership of 9,315,002 shares, representing 5.00% of the company’s common stock as of December 31, 2025.
RBC reports no sole voting or dispositive power over these shares, but shared voting and shared dispositive power over all 9,315,002 shares. The filing identifies RBC Capital Markets, LLC, a registered broker-dealer subsidiary, as the relevant entity involved in acquiring the securities.
The certification states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of American Healthcare REIT, nor as part of any control-related transaction.
American Healthcare REIT, Inc. executive Mark E. Foster reported a tax-related share disposition. On February 9, 2026, the company repurchased 7,685 shares of common stock at $48.77 per share from Foster to cover his tax obligations from vesting restricted stock. Following this tax-withholding transaction, Foster directly beneficially owns 49,915 shares of American Healthcare REIT common stock.
Oh Stefan K.L. reported disposition transactions in a Form 4 filing for AHR. The filing lists transactions totaling 10,166 shares at a weighted average price of $48.77 per share. Following the reported transactions, holdings were 85,505 shares.
Willhite Gabriel M reported disposition transactions in a Form 4 filing for AHR. The filing lists transactions totaling 17,133 shares at a weighted average price of $48.77 per share. Following the reported transactions, holdings were 131,352 shares.
PEAY BRIAN reported disposition transactions in a Form 4 filing for AHR. The filing lists transactions totaling 20,109 shares at a weighted average price of $48.77 per share. Following the reported transactions, holdings were 157,587 shares.
Prosky Danny reported disposition transactions in a Form 4 filing for AHR. The filing lists transactions totaling 29,992 shares at a weighted average price of $48.77 per share. Following the reported transactions, holdings were 299,035 shares.